Combo pills perks up firms’ profit
Published: 2010-05-28 06:58:00
Updated: 2010-05-28 06:58:00
Influenced by the recent announcement of the drug agency announcement that 507 combination drugs should be subject to bioequivalence testing from this October, a growing number of companies are rushing to produce combo drugs
Seoul Pharmaceutical Laboratory, a local bioequivalence testing age...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
